Thomas Reiser/LinkedIn
Oct 18, 2025, 05:21
Thomas Reiser: ISTH Guidelines and Guidance Committee Invites Public Comments on the Guidance Manuscript
Thomas Reiser, Executive Director of the International Society on Thrombosis and Haemostasis (ISTH), shared on LinkedIn:
“Your expertise is requested!
The International Society on Thrombosis and Haemostasis (ISTH) Guidelines & Guidance Committee invites public comments on the guidance manuscript, “Development of New Antithrombotic Drugs for Children (Part 1): Guidance from the SSC Subcommittee on Pediatrics & Neonatal Thrombosis and Hemostasis and the Pedi-ATLAS Group”
Deadline: Oct. 30″
Register here.
Stay informed with Hemostasis Today.
-
Dec 11, 2025, 13:59Jeff Schaffnit Shares Sanofi’s Patient Advocacy Voices Series with Caroline Kruse
-
Dec 11, 2025, 12:50Harlan Krumholz on Half-Life of Evidence and The Need for Real-Time Trials
-
Dec 11, 2025, 12:34Riitta Lassila on LMWH Benefits in COVID19
-
Dec 11, 2025, 12:30A Neutrophil-Mesangial Cell Axis Promotes Glomerular Injury in Lupus Nephritis
-
Dec 11, 2025, 12:27Roula Farah: Discussing Rare Bleeding Disorders in Abu Dhabi
-
Dec 11, 2025, 12:21Amirali Ebrahimpour: Escherichia coli–Related DIC Case Report
-
Dec 11, 2025, 12:08Laura Girardi Compares US, CT and MRI in Portal Vein Thrombosis
-
Dec 11, 2025, 11:55Dino Mehic on BDUC: What Do We Know?
-
Dec 11, 2025, 11:39Post‑ASH25 Reflection from Hollie Knight: The Magic Isn’t Just in the Data, It’s in How We Move It